February 24, 2005
New New New!!
Memory Testing Corporation announces with pleasure its
launch of its new breast cancer detection and discrimination:
The Breast Cancer Detection and Discrimination System (BCDDS).
It is a fast, reliable, accurate and efficient system to locate and determine using DCE-MRI of the breast, and helps to determine quickly and reliably whether cancer is present or not.If cancer is detected, it's location in three dimensions, its size, its volume, its surface characteristics are made apparent, and these with other filters and assessments help in giving an indicator of the type of cancer than has been detected. If you are interested, read more here. Also, to download a fact sheet. Click here
**************
Memory Testing Corporation announces with great pleasure the release of the Brockway Memory Assessment Battery (BMAB 5.0) Version 5.0, for Windows. This version will run under any version of Windows, and now will run on any platform using Mac OS X
Windows version
A Trial version of the BMAB 5.0 for Windows may be downloaded now, for free. This trial gives a feeling for the ease of use and the scope of the full battery may be seen. While only one of the modules is active, the user will see from the manual, what the other modules do, how they perform. The BMAB manual is also available as a free downloadable .pdf file. With purchase, highly detailed scoring sheets and norms accompany the test. To download go to
http://www.memorytesting.com/bmaba.htm
The BMAB Mac OS X Version.
Other Corporate News
July 28, 2004. Davidson, NC
The paper describes an approach to finding breast cancer in difficult breast cancer cases.
July 11, 2003. Davidson, NC.
John P. Brockway, Ph.D., President and CEO of Memory Testing Corporation, presented an invited address at the Presbyterian Hospital Breast Cancer Forum entitled, "Breast Cancer Detection, Localization, Discrimination, and Quantification in Gadolinium Enhanced MRI Dynamic Images Using 4D Volumetric Computerized Visualization on July 11, 2003.
The software was developed to find breast cancer in women who have had negative mammograms, and negative ultrasounds, but nonetheless, either they or their physician felt there is something suspicious with their breast
The presentation highlighted new software that Dr. Brockway, Benjamin Carruthers and Dr. Subramanian have developed over the last 18 months. This software can and does detect with high sensitivity breast cancer. It can discriminate various forms of breast cancer with high specificity. It can and does reveal the location(s) of the cancer in three dimensions and determines if the cancer is uni-focal or multi-focal, and the software gives accurate reliable estimates of the entire tumor volume as well as the localized volume. It was designed to reduce the inherent tendency toward false positives from standard MRI of the breast.
This software will be valuable in detecting difficult to find cancer in women with dense breasts, women who are at higher risk genetically and/or women who have a higher familial risk of breast disease.
October 14, 2002. Davidson, NC.
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., together with Angelina A. Tzacheva and Kayvan Najarian, Ph.D, have had their manuscript accepted for publication in the Journal of Magnetic Resonance Imaging.
The title of the manuscript is:
Breast Cancer Detection in Gadolinium Enhanced MR Images by Static Region Descriptors and Neural Networks Journal of Magnetic Resonance Imaging 2003, 17(3) 337-342
This work describes the advanced use of Magnetic Resonance Imaging parameters combined with computerized methods of examining images to detect and locate, as well as classify, breast cancer in women. These are women who have had negative results from mammographic tests as well as negative results from ultrasonography tests, but either they or their physician felt that there was suspicion to investigate further. Using T1 dynamic series, as well as spectral spatial analyses, tumors and their extent, their margins, were located with five static region descriptors and the tumors were classified using neural networks which were trained on previous data sets. High sensitivity as well as high specificityfor this method were reported.
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., together with Angelina A. Tzacheva, gave an invited address to the Presbyterian Healthcare Breast Tumor Forum, June 23, in Charlotte, NC. They have developed together a manner of detecting breast cancer which from the surface characteristics of gadolinium enhanced dynamic T1 MRI images.
The title of the address was:
Breast Cancer Detection in Gadolinium Enhanced MR Images by Static Region Descriptors and Neural Networks
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., gave an invited address to the Department of Speech Pathology at the Charlotte Institute of Rehabilitation, Carolinas Medical Center, Charlotte, NC on November 27, 2001. He used three studies to highlight regions of brain known to be important to the reception and production of speech, including the basal temporal language area (BTLA) in fusiform gyrus. He described various linguistic memory tasks that help to activate posterior hippocampal regions.
The title of the address was:
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., gave Grand Rounds in Neurosurgery at the University of Colorado Health Sciences Center in Denver on Wednesday, July 25, 2001. Dr. Brockway characterized various regions of brain which are called eloquent cortex. He used fMRI studies with brain tumors or temporal lobe epilepsy to describe the manner and many uses of the computer modules and methods developed especially to determine where language and memory centers were in these individual brains, including the correspondence between this technique and awake intraoperative mapping. He conducted informal sessions with members of the NeuroOncology group, the NeuroRadiology group and met with neurosurgeons about reliability of fMRI and of mapping patients in Denver.
The title of the address was:
Characterization of Eloquent Brain Regions with Functional MRI
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., gave Grand Rounds in Neurosurgery at the University of Oklahoma Health Sciences Center in Oklahoma City on Thursday, 19 July, 2001, Dr. Brockway characterized various regions of brain which are called eloquent cortex. He used fMRI studies to describe in various individuals the manner and many of the computer modules and methods developed especially to determine where language and memory centers were, including the correspondence between this technique and awake intraoperative mapping.
The title of the address was:
Characterization of Eloquent Brain Regions with Functional MRI
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., gave an invited address in the first session on Diagnostic Techniques: "Issues in the Contemporary Management of Brain Tumors," Diagnostic Techniques of the William R Pitts Neuroscience Symposium and Memorial Lecture, Tuesday, May 1, 2001, Charlotte, NC. Dr. Brockway characterized various regions of brain which are called eloquent cortex. He used fMRI studies to describe in various individuals the manner and methods to determine where their language and memory centers were, including the correspondence between this technique and awake intraoperative mapping.
The title of the address was:
The title of the paper is:Characterization of Eloquent Brain Regions with Functional MRI
John P. Brockway, Ph.D., President and CEO of Memory Testing Corp., published a paper which details how a non-invasive magnetic resonance imaging test will replace a highly invasive catheterization test, and do so for far less cost. If this procedure is adopted, it will reduce surgical and anesthetic risk to each patient, to the hospital, and to the physician and it will yield higher patient outcomes.
Two functional magnetic resonance imaging f(MRI) tasks that may replace the gold standard, Wada testing, for language lateralization while giving additional localization information.The titles of the papers are:Brain & Cognition, 2000, Jun-Aug,;43(1-3):57-9
Dr. Brockway delivered two papers at the Sixth Annual Meeting of the Organization for Human Brain Mapping, held in San Antonio, Texas, June 12-16, 2000.
Functional Magnetic Resonance Imaging (fMRI) May Replace the WADA test for language lateralization/localization;His Topic was:NeuroImage, 2000, 11(5):S277
NeuroImage, 2000, 11(5):S917
Dr. Brockway delivered Grand Rounds at the Medical College of Georgia, Augusta Georgia, July 28, 2000 in the Neurosurgery Amphitheater on the 3rd floor of the Main Hospital.
When and Why Will Functional Magnetic Resonance Imaging (fMRI) replace the WADA (IAT) test andHow Will fMRI Improve Patient Outcome?
